Status:
COMPLETED
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Primary Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to compare the efficacy and safety of Timolol 0.5% solution to Brinzolamide 1% each given twice daily when added to Travoprost 0.004% given each evening.
Eligibility Criteria
Inclusion
- Patients who are treated with any prostaglandin analogue monotherapy (excluding unoprostone) and who have an intraocular pressure between 19 and 32 mmHg at 08:00 hours.
Exclusion
- Under 18 years
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
245 Patients enrolled
Trial Details
Trial ID
NCT00372827
Start Date
February 1 2004
End Date
January 1 2006
Last Update
November 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mainz Site
Mainz, Germany, 55131